Peptides naturally presented by MHC class I molecules.

MHC class I molecules are peptide receptors of stringent specificity which however still allow millions of different ligands. This is achieved by the following specificity characteristics summarized as allele specific peptide motifs: Peptides are of defined length, depending on the class I allele (either 8 or 9 residues; exceptions have been observed). Typically, 2 of the 8 or 9 positions are anchors that can only be occupied by a single amino acid residue, or by residues with closely related side chains. Location and characteristics of anchors vary with class I alleles. The C terminus of the peptide ligands is frequently an aliphatic or charged residue. Such allele-specific class I peptide ligand motifs, known so far for H-2Kd, Kb, Kk, Kkm1, Db, HLA-A*0201, A*0205, and B*2705, are useful to predict natural T cell epitopes. The latter can be determined by extraction from cells recognized by the T cell of interest. It is not known how the class I ligands are produced in the cell, although speculative models exist. The peptide specificity of class I molecules and experimental evidence indicate that T cells are tolerant to only a small fraction of the expressed genomic sequences and are not tolerant to the remainder. The function of class I molecules is to present a collection of self-peptide samples at the cell surface for surveillance by T cells.

[1]  M. Bednarek,et al.  The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. , 1991, Journal of immunology.

[2]  M. Bevan,et al.  Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Claverie,et al.  Working principles in the immune system implied by the "peptidic self" model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Rammensee,et al.  Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.

[5]  O. Rötzschke,et al.  Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.

[6]  R. Zinkernagel,et al.  Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Rammensee,et al.  Identification of classical minor histocompatibility antigen as cell-derived peptide , 1990, Nature.

[8]  V. Nussenzweig,et al.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.

[9]  J. Rodgers,et al.  Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta , 1990, The Journal of experimental medicine.

[10]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[11]  H. Rammensee,et al.  Isolation of human minor histocompatibility peptides. , 1992, International immunology.

[12]  D. Anderson,et al.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.

[13]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[14]  N. Huskisson,et al.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.

[15]  H. Rammensee,et al.  Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.

[16]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[17]  P. Chomez,et al.  Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide , 1990, The Journal of experimental medicine.

[18]  M. A. Saper,et al.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.

[19]  H. Rammensee,et al.  Limit of T cell tolerance to self proteins by peptide presentation. , 1990, Science.

[20]  T. Boon,et al.  Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells , 1989, Cell.

[21]  P. Weber,et al.  Competitor analogs for defined T cell antigens: Peptides incorporating a putative binding motif and polyproline or polyglycine spacers , 1990, Cell.

[22]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[23]  J. Whitton,et al.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.

[24]  J. Yewdell,et al.  Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.

[25]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[26]  Timothy E. Elliott,et al.  The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.

[27]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[28]  Hans-Georg Rammensee,et al.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.

[29]  L. Sherman,et al.  Alloreactive T cells discriminate among a diverse set of endogenous peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Rammensee,et al.  Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. , 1992, International immunology.

[31]  H. Rammensee,et al.  Evidence from in vitro studies that tolerance to self antigens is MHC-restricted , 1984, Nature.

[32]  B. Jordan,et al.  H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide , 1986, Nature.

[33]  J. Cerottini,et al.  Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA , 1988, The Journal of experimental medicine.

[34]  P. Romero,et al.  H-2Kd-restricted antigenic peptides share a simple binding motif , 1991, The Journal of experimental medicine.

[35]  R. Webster,et al.  Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. , 1984, Journal of immunology.

[36]  L. Sherman,et al.  Peptide-dependent recognition of H–2Kb by alloreactive cytotoxic T lymphocytes , 1989, Nature.

[37]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[38]  O. Werdelin Determinant Protection. A Hypothesis for the Activity of Immune Response Genes in the Processing and Presentation of Antigens by Macrophages , 1986, Scandinavian journal of immunology.

[39]  J. Strominger,et al.  Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Ploegh,et al.  Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells , 1991, European journal of immunology.

[41]  H. Rammensee,et al.  Peptide motifs of closely related HLA class I molecules encompass substantial differences , 1992, European journal of immunology.

[42]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[43]  D. Nixon,et al.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.

[44]  P. Lauzurica,et al.  Structural identity between HLA-A2 antigens differentially recognized by alloreactive cytotoxic T lymphocytes. , 1991, Journal of immunology.

[45]  T Spies,et al.  Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Zinkernagel,et al.  Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease , 1989, European journal of immunology.

[47]  R. Jaenisch,et al.  Endogenous retroviruses lead to the expression of a histocompatibility antigen detectable by skin graft rejection. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  F. Lemonnier,et al.  β2-Microglobulin restriction of antigen presentation , 1990, Nature.

[49]  U. Koszinowski,et al.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.

[50]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[51]  S. Nathenson,et al.  The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[53]  J. Frelinger,et al.  Evidence of widespread binding of HLA class I molecules to peptides , 1990, The Journal of experimental medicine.

[54]  Günter J. Hämmerling,et al.  Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex , 1991, Nature.

[55]  R. Moots,et al.  Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytes , 1992, European journal of immunology.

[56]  H. Rammensee,et al.  Restricted recognition of β2-microglobulin by cytotoxic T lymphocytes , 1986, Nature.

[57]  A. Singer,et al.  Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens , 1983, The Journal of experimental medicine.

[58]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[59]  E. Goulmy,et al.  Y-antigen killing by T cells of women is restricted by HLA , 1977, Nature.

[60]  R. Zinkernagel,et al.  Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide , 1991, European journal of immunology.

[61]  T. Boon,et al.  The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice , 1991, The Journal of experimental medicine.

[62]  A. Vitiello,et al.  The role of beta 2-microglobulin in peptide binding by class I molecules. , 1990, Science.

[63]  H. von Boehmer,et al.  Self-nonself discrimination by T cells. , 1990, Science.

[64]  J. Rothbard,et al.  A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes , 1989, Nature.

[65]  Robert DeMars,et al.  Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.

[66]  H. Eisen,et al.  A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein , 1992, Cell.

[67]  R. Linsk,et al.  Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[69]  C. Mackay,et al.  Qa-1 restricted recognition of foreign antigen by a γδ T-cell hybridoma , 1989, Nature.

[70]  H. Rammensee,et al.  Self tolerance of natural MHC class I ligands. , 1993, International reviews of immunology.

[71]  P. Chomez,et al.  Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[72]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[73]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[74]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Graff,et al.  Recognition of the beta-2 microglobulin-B molecule by a CTL clone. , 1987, Journal of immunology.

[76]  J. Monaco,et al.  Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene , 1991, Nature.

[77]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[78]  J. Levy,et al.  Physical association between MHC class I molecules and immunogenic peptides , 1989, Nature.

[79]  R. Germain Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.

[80]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.

[81]  G. Brownlee,et al.  Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin , 1991, Journal of virology.

[82]  T. Braciale,et al.  Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes , 1991, The Journal of experimental medicine.

[83]  M. Luscher,et al.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.

[84]  M. Cohn,et al.  Is the establishing of tolerance to self obligatorily MHC restricted? , 1992, Immunology letters.

[85]  S. Beck,et al.  Second proteasome-related gene in the human MHC class II region , 1991, Nature.

[86]  H. Yonekawa,et al.  Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.

[87]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[88]  P. Chomez,et al.  Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. , 1989, Cold Spring Harbor symposia on quantitative biology.

[89]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[90]  H. Rammensee,et al.  Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression , 1991, Cell.

[91]  M. Bevan Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier , 1975, Nature.

[92]  H. Grey,et al.  Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme , 1989, Nature.

[93]  A. Townsend,et al.  Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.